Great Valley Advisor Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.29M Buy
52,491
+7,573
+17% +$606K 0.06% 278
2025
Q4
$4.28M Buy
44,918
+5,688
+14% +$558K 0.08% 213
2025
Q3
$3.83M Sell
39,230
-1,427
-4% -$148K 0.08% 217
2025
Q2
$4.37M Buy
40,657
+1,830
+5% +$185K 0.1% 192
2025
Q1
$3.92M Sell
38,827
-1,336
-3% -$135K 0.08% 207
2024
Q4
$3.59M Sell
40,163
-292
-0.7% -$25.7K 0.08% 229
2024
Q3
$3.39M Buy
40,455
+1,074
+3% +$84.7K 0.08% 234
2024
Q2
$3.03M Buy
39,381
+3,577
+10% +$262K 0.08% 229
2024
Q1
$2.45M Sell
35,804
-130
-0.4% -$8.36K 0.07% 241
2023
Q4
$2.08M Buy
35,934
+9,859
+38% +$526K 0.07% 235
2023
Q3
$1.38M Buy
26,075
+1,371
+6% +$71.9K 0.06% 271
2023
Q2
$1.34M Buy
24,704
+3,157
+15% +$165K 0.06% 272
2023
Q1
$1.08M Buy
21,547
+8,580
+66% +$404K 0.05% 293
2022
Q4
$600K Sell
12,967
-149
-1% -$6.45K 0.03% 408
2022
Q3
$508K Buy
13,116
+474
+4% +$19K 0.03% 416
2022
Q2
$471K Buy
12,642
+4,457
+54% +$181K 0.03% 437
2022
Q1
$362K Buy
8,185
+2,896
+55% +$126K 0.02% 459
2021
Q4
$225K Buy
5,289
+358
+7% +$15K 0.01% 551
2021
Q3
$214K Buy
+4,931
New +$218K 0.01% 539

Other funds holding BSX

Great Valley Advisor Group's BSX Position: Q1 2026 in Review

Great Valley Advisor Group increased its Boston Scientific (BSX) stake by 17% in Q1 2026, buying an estimated $606K and bringing the position to 52,491 shares worth $3.29M. The position accounts for 0.06% of the portfolio, ranked #278.

Great Valley Advisor Group first reported a position in BSX in Q3 2021 and has held it in 19 quarters since. The position peaked at $4.37M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Great Valley Advisor Group held 52,491 shares of Boston Scientific worth $3.29M as of Q1 2026.
  • Great Valley Advisor Group bought 7,573 Boston Scientific shares in Q1 2026, an estimated $606K.
  • Boston Scientific made up 0.06% of Great Valley Advisor Group's portfolio in Q1 2026, its #278 holding.
  • Great Valley Advisor Group first reported a position in Boston Scientific in Q3 2021 and has held it in 19 quarters since.
  • Great Valley Advisor Group's Boston Scientific position peaked at $4.37M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Great Valley Advisor Group's 13F filing for Q1 2026, filed 11 May 2026.